Mr Charles Gore
Executive Director, Medicines Patent Pool
Charles Gore is the Executive Director of the Medicines Patent Pool (MPP). He took up the post in July 2018 following a career in patient representation and public health advocacy. He has overseen MPP’s rapid expansion into drugs on, or likely candidates for, the WHO Essential Medicines List, COVID-19 health products and, most recently, technology transfer, including the establishment of a mRNA technology transfer hub in South Africa, in partnership with WHO.
He was diagnosed with hepatitis C in 1995 and cirrhosis in 1998. In 2000 he set up The Hepatitis C Trust in the UK which he ran for 18 years. In 2002 he was treated and cured of the virus. He helped create the European Liver Patients Association and was its first President in 2004. In 2007 he established the World Hepatitis Alliance and was President until December 2017. As a result of advocacy by the Alliance, WHO adopted successive viral hepatitis resolutions in 2010, 2014 and 2016, culminating in endorsement of the goal of eliminating hepatitis B and C by 2030. In addition to direct advocacy with over 50 Ministries of Health, Charles has led on advising countries on finding sustainable domestic financing for hepatitis programs. Charles was a member of all the WHO guideline development groups on testing and treating viral hepatitis.